Price
$408.17+5.28%1Y
1M-2.31%1Y+5.28%
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Below average4/10
Value51
Quality60
Momentum25
Growth29
P/E (TTM)16.1
Market Cap$84.37B
1Y Return+5.28%
5Y Return+9.02%
Business Segments
Revenue split by operating segment, from SEC XBRL filings.
Latest period: Q1 2026Total $62.63B (-0.63%)
●Carelon Rx Segment grew +7.16% YoY●Reportable Segments +2.64% YoY
SegmentLatestQoQYoY
- Reportable Segments$50.18B-1.05%+2.64%
- Carelon Rx Segment$6.22B+1.07%+7.16%
- Total Carelon$6.22B+1.07%+7.16%
- Carelon Services Segment$0.00--
- Carelon Total---
- Corporate And Other$0.00--
- Health Benefits Segment$0.00--